+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Lipid Market Size, Share & Industry Trends Analysis Report By Application, By Source, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon


  • 74 Pages
  • May 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5615658
The Latin America, Middle East and Africa Lipid Market is expected to witness market growth of 10.0% CAGR during the forecast period (2022-2028).

Lipids are a type of chemical that is insoluble in water but soluble in chloroform, alcohol, and other non-polar cleansers. Along with carbohydrates and proteins, they are typically found in plant and animal cells. Growing consumer awareness of the product's health benefits, shifts in customer preferences, and a shift toward a healthier lifestyle all have an impact on the lipid market's growth. Furthermore, over the forecast period, product developments, growth in the number of applications, and rising demand for the product in developing countries provide profitable prospects for market companies.

Lipids come in a variety of shapes and functions. Triacylglycerols (TAGs) are the most prevalent lipids, and they are utilized by plants for extensive energy storage. Humans consume lipids from vegetables on a daily basis, such as cooking oil (>99 percent lipids) or nuts and seeds (up to 75 percent). Humans must consume some plant fats, while others are highly suggested for disease prevention reasons.

Mexico is the world's greatest user of sugary drinks, as well as the country with the world's largest fat population: 71.3 percent of adults are obese or overweight. Diabetes prevalence was 9.2% in 2012, which indicates that 12 million persons aged 20 and up have the disease. Only about 80% of those who have been diagnosed receive therapy. Only 25% of patients met their treatment goals, putting 24.7 percent at intermediate risk and 49.8 percent at extremely high risk of developing problems. As a result, the disease has become the leading cause of outpatient medical treatment, hospitalization, blindness, chronic renal failure, and non-traumatic amputations.

Diabetes is also the leading cause of death in persons aged 55 to 74, and its prevention and treatment costs 2.4 percent of GDP. Diabetes prevalence is expected to rise to between 14 percent and 22 percent by 2050.

The Brazil market dominated the LAMEA Lipid Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $256.3 Million by 2028. The Argentina market is estimated to grow at a CAGR of 10.6% during (2022 - 2028). Additionally, The UAE market is expected to witness a CAGR of 9.7% during (2022 - 2028).

Based on Application, the market is segmented into Food & Beverages, Pharmaceuticals, Nutrition & Supplements, and Others. Based on Source, the market is segmented into Plant-based and Animal-based. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Archer Daniels Midland Company, BASF SE, Koninklijke DSM N.V., Reckitt Benckiser Group PLC, Kerry Group PLC, Clover Corporation Limited, Croda International PLC, FMC Corporation, Cargill Corporation, and Nordic Naturals, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Application

  • Food & Beverages
  • Pharmaceuticals
  • Nutrition & Supplements
  • Others

By Source

  • Plant-based
  • Animal-based

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Archer Daniels Midland Company
  • Koninklijke DSM N.V.
  • Reckitt Benckiser Group PLC
  • Kerry Group PLC
  • Clover Corporation Limited
  • Croda International PLC
  • FMC Corporation
  • Cargill Corporation
  • Nordic Naturals, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Lipid Market, by Application
1.4.2 LAMEA Lipid Market, by Source
1.4.3 LAMEA Lipid Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Lipid Market
Chapter 4. LAMEA Lipid Market by Application
4.1 LAMEA Food & Beverages Market by Country
4.2 LAMEA Pharmaceuticals Market by Country
4.3 LAMEA Nutrition & Supplements Market by Country
4.4 LAMEA Others Market by Country
Chapter 5. LAMEA Lipid Market by Source
5.1 LAMEA Plant-based Market by Country
5.2 LAMEA Animal-based Market by Country
Chapter 6. LAMEA Lipid Market by Country
6.1 Brazil Lipid Market
6.1.1 Brazil Lipid Market by Application
6.1.2 Brazil Lipid Market by Source
6.2 Argentina Lipid Market
6.2.1 Argentina Lipid Market by Application
6.2.2 Argentina Lipid Market by Source
6.3 UAE Lipid Market
6.3.1 UAE Lipid Market by Application
6.3.2 UAE Lipid Market by Source
6.4 Saudi Arabia Lipid Market
6.4.1 Saudi Arabia Lipid Market by Application
6.4.2 Saudi Arabia Lipid Market by Source
6.5 South Africa Lipid Market
6.5.1 South Africa Lipid Market by Application
6.5.2 South Africa Lipid Market by Source
6.6 Nigeria Lipid Market
6.6.1 Nigeria Lipid Market by Application
6.6.2 Nigeria Lipid Market by Source
6.7 Rest of LAMEA Lipid Market
6.7.1 Rest of LAMEA Lipid Market by Application
6.7.2 Rest of LAMEA Lipid Market by Source
Chapter 7. Company Profiles
7.1 Archer Daniels Midland Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments: Product Launches and Product Expansions: Acquisition and Mergers:
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments: Product Launches and Product Expansions: Partnerships, Collaborations, and Agreements:
8.3 Koninklijke DSM N.V.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments: Product Launches and Product Expansions:
8.4 Reckitt Benckiser Group PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Kerry Group PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Clover Corporation Limited
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.7 Croda International PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments: Acquisition and Mergers:
8.8 FMC Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.9 Cargill Corporation
8.9.1 Company Overview
8.10. Nordic Naturals, Inc.
8.10.1 Company Overview

Companies Mentioned

  • Archer Daniels Midland Company
  • Koninklijke DSM N.V.
  • Reckitt Benckiser Group PLC
  • Kerry Group PLC
  • Clover Corporation Limited
  • Croda International PLC
  • FMC Corporation
  • Cargill Corporation
  • Nordic Naturals, Inc.